Antibody response to Haemophilus influenzae type b capsular... : The Pediatric Infectious
Disease Journal Antibody response to Haemophilus influenzae type b capsular polysaccharide …

Thirty children vaccinated at 2 to 17 months of age with Haemophilus influenzae type b
polysaccharide linked to a partially purified 40,000 dalton outer membrane protein of …

Haemophilus influenzae type b (Hib) is an important pathogen in children< 5 years of age.
The Hib conjugate vaccines were the first polysaccharide–protein conjugate vaccines to be …

Vaccination of infants with Haemophilus influenzae type b (Hib) capsular polysaccharide
(HibCP) coupled to carrier proteins has proven protective against invasive Hib diseases in …

A long-term follow-up of approximately 50,000 children who received the Hemophilus
influenzae type b capsular polysaccharide vaccine in 1974 at three months to five years of …

Background The incidence of invasive Haemophilus influenzae infection decreased
dramatically since the introduction of the H. influenzae serotype b (Hib) conjugate vaccine …

Although systemic infections caused by Haemophilus influenzae type b occur worldwide,
detailed epidemiologic data are available in but a few countries. 1-3 The public health …

Objective.—To determine the incidence of invasiveHaemophilus influenzaetype b disease in
children living in Minnesota and Dallas County, Texas, before and since introduction of plain …

Concentrations of serum anti—Haemophilus influenzae type b (anti-Hib) capsular
polysaccharide (CPS)⩾ 0.15 and⩾ 1.0 µ g/mL are widely used as surrogates for protection …

In a prospective, randomized, double-blind efficacy trial, the immunogenicity of 10 lots of
Haemophilus injluenzae type b capsular polysaccharide-tetanus toxoid conjugate vaccine …